In addition to inhibition of SGLT2, the improvement in hepatic steatosis and lipid synthesis may be mediated via up-regulation of PPARα1 and down-regulation of DGAT2, PPARγ1 and PPARγ2. Here, SLC5A2 is linked to Hepatic steatosis.